Biguanides and lactic acidosis. 1977

P J Phillips, and D W Thomas, and P E Harding

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide

Related Publications

P J Phillips, and D W Thomas, and P E Harding
January 1978, Duodecim; laaketieteellinen aikakauskirja,
P J Phillips, and D W Thomas, and P E Harding
March 1978, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
P J Phillips, and D W Thomas, and P E Harding
October 1973, Lakartidningen,
P J Phillips, and D W Thomas, and P E Harding
August 1997, Revista clinica espanola,
P J Phillips, and D W Thomas, and P E Harding
July 1974, The New Zealand medical journal,
P J Phillips, and D W Thomas, and P E Harding
October 1972, Minerva medica,
P J Phillips, and D W Thomas, and P E Harding
January 1976, La Nouvelle presse medicale,
P J Phillips, and D W Thomas, and P E Harding
February 1996, Harefuah,
P J Phillips, and D W Thomas, and P E Harding
January 1978, British medical journal,
P J Phillips, and D W Thomas, and P E Harding
December 1977, British medical journal,
Copied contents to your clipboard!